AMENDMENT NO.1 TO COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • August 6th, 2010 • Micromet, Inc. • Biological products, (no disgnostic substances)
This AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT (this “Amendment”) is entered into as of April 30, 2010, by and between KINGSBRIDGE CAPITAL LIMITED, an entity organized and existing under the laws of the British Virgin Islands, whose business address is P.O. Box 1075, Elizabeth House, 9 Castle Street, St. Helier, Jersey, Channel Islands (the “Investor”), and MICROMET, INC., a corporation organized and existing under the laws of the State of Delaware (the “Company”).
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • August 6th, 2010 • Micromet, Inc. • Biological products, (no disgnostic substances)
This Collaboration and License Agreement (the “Agreement”) is made and entered into effective as of May 5, 2010 (the “Effective Date”), by and between Micromet AG, having its principal place of business at Staffelseestrasse 2, 81477 Munich, Germany (VAT-ID No.: DE811666912) (“Micromet”), and Boehringer Ingelheim International GmbH, having its principal place of business at Binger Str. 173, 55216 Ingelheim, Germany (VAT-ID No: DE 811138149) (“BI”). Micromet and BI each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
